Olympus (TSE:7733) Total Liabilities: 円725,122 Mil (As of Mar. 2026)

What is Olympus Total Liabilities?

Olympus TSE:7733 +0.72% 80 Total Liabilities is 円725,122 Mil as of Mar. 2026. GuruFocus rates TSE:7733 with a GF Score™ of 80/100 and a GF Value™ of 円2,598.95 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Olympus's Total Liabilities for the quarter that ended in Mar. 2026 was 円725,122 Mil.

Olympus's quarterly Total Liabilities increased from Sep. 2025 (円651,212.00 Mil) to Dec. 2025 (円684,569.00 Mil) and increased from Dec. 2025 (円684,569.00 Mil) to Mar. 2026 (円725,122.00 Mil).

Olympus's annual Total Liabilities declined from Mar. 2024 (円777,030.00 Mil) to Mar. 2025 (円681,540.00 Mil) but then increased from Mar. 2025 (円681,540.00 Mil) to Mar. 2026 (円725,122.00 Mil).

Olympus Total Liabilities Related Terms

Olympus Total Liabilities Historical Data

* Premium members only.

The historical data trend for Olympus's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Olympus Total Liabilities Chart

Olympus Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Total Liabilities

Get a 7-Day Free Trial

846,637.00

867,467.00

777,030.00

681,540.00

725,122.00

Olympus Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Liabilities	Get a 7-Day Free Trial															681,540.00	708,274.00	651,212.00	684,569.00	725,122.00

80GF Score

Olympus Corp TSE:7733

Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Olympus Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Olympus's Total Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	436874	+	(159700	+	108529
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	20019	+	0)
	=	725,122

Total Liabilities	=	Total Assets (A: Mar. 2026 )	-	Total Equity (A: Mar. 2026 )
	=	1537162	-	812040
	=	725,122

Olympus's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	436874	+	(159700	+	108529
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	20019	+	0)
	=	725,122

Total Liabilities	=	Total Assets (Q: Mar. 2026 )	-	Total Equity (Q: Mar. 2026 )
	=	1537162	-	812040
	=	725,122

Frequently Asked Questions Learn more about Total Liabilities →

What does a Total Liabilities of 円725,122 Mil mean?

Olympus (TSE:7733) has a Total Liabilities of 円725,122 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Olympus and its competitors.

Is Olympus' Total Liabilities too high?

Olympus' current Total Liabilities is 円725,122 Mil. Overall, Olympus has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Olympus' Total Liabilities compare to ABT and SYK?

Olympus' Total Liabilities of 円725,122 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Liabilities for a Medical Devices & Instruments company?

A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Liabilities mean?

A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Olympus and its competitors. Olympus's current Total Liabilities is 円725,122 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Olympus stock overvalued right now?

Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,598.95, compared to a current price of 円1,753.50 — trading 32.5% below its estimated fair value. The current Total Liabilities is 円725,122 Mil. Olympus' overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Liabilities calculated?

Total Liabilities is calculated from a company's financial statements. For Olympus (TSE:7733), the current Total Liabilities is 円725,122 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Olympus (TSE:7733) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of 円1,753.50 is trading 32.5% below its estimated GF Value™ of 円2,598.95. GuruFocus considers Olympus to be Significantly Undervalued.

Key valuation signals for TSE:7733:

Total Liabilities: 円725,122 Mil
GF Value™: 円2,598.95 vs. price of 円1,753.50 (32.5% below fair value)
GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Olympus Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TSE:6869 TSE:6960 TSE:6849 TSE:6523 TSE:7575 TSE:4549 TSE:7779 TSE:6823 TSE:7777 TSE:4548 ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Other Exchanges OLYMY:USA OCPNF:USA OLY1:Germany

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507

Website https://www.olympus.co.jp

Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.

80GF Score

Get the complete analysis for TSE:7733

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,753.50

Price

円2,598.95

GF Value

View TSE:7733 Analysis

See Total Liabilities data for all stocks →